Fate Therapeutics, Inc.FATENASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank29
3Y CAGR-8.7%
5Y CAGR-22.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-8.7%/yr
vs -24.7%/yr prior
5Y CAGR
-22.6%/yr
Recent acceleration
Acceleration
+15.9pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $46.63M | +29.3% |
| 2024 | $36.06M | -13.9% |
| 2023 | $41.87M | -31.7% |
| 2022 | $61.33M | -54.1% |
| 2021 | $133.58M | -20.2% |
| 2020 | $167.35M | +67.7% |
| 2019 | $99.81M | -47.6% |
| 2018 | $190.51M | +114.2% |
| 2017 | $88.95M | +0.4% |
| 2016 | $88.61M | - |